Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2
Authors
Keywords
-
Journal
SLEEP
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-06-26
DOI
10.1093/sleep/zsaa123
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety of Lemborexant Versus Placebo and Zolpidem: Effects on Auditory Awakening Threshold, Postural Stability, and Cognitive Performance in Healthy Older Subjects in the Middle of the Night and Upon Morning Awakening
- (2020) Patricia Murphy et al. Journal of Clinical Sleep Medicine
- Untreated Insomnia Increases All-Cause Health Care Utilization and Costs among Medicare Beneficiaries
- (2019) Emerson M Wickwire et al. SLEEP
- The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases
- (2018) Chunmei Wang et al. Frontiers in Molecular Neuroscience
- On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers
- (2018) Annemiek Vermeeren et al. SLEEP
- Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline
- (2017) Michael J. Sateia et al. Journal of Clinical Sleep Medicine
- Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study
- (2017) Patricia Murphy et al. Journal of Clinical Sleep Medicine
- In Vitro and In Silico Characterization of Lemborexant (E2006), a Novel Dual Orexin Receptor Antagonist
- (2017) Carsten Theodor Beuckmann et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Long-Term Efficacy and Safety of Zolpidem Extended-Release 12.5 mg, Administered 3 to 7 Nights Per Week for 24 Weeks, in Patients With Chronic Primary Insomnia: A 6-Month, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study
- (2017) Andrew D. Krystal et al. SLEEP
- A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Effect of Eszopiclone 2 mg on Sleep/Wake Function in Older Adults with Primary and Comorbid Insomnia
- (2017) Sonia Ancoli-lsrael et al. SLEEP
- Twelve Months of Nightly Zolpidem Does Not Lead to Dose Escalation: A Prospective Placebo-Controlled Study
- (2017) Timothy A. Roehrs et al. SLEEP
- Efficacy and Safety of 6-Month Nightly Ramelteon Administration in Adults with Chronic Primary Insomnia
- (2017) SLEEP
- Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials
- (2016) W. Joseph Herring et al. BIOLOGICAL PSYCHIATRY
- Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial
- (2014) David Michelson et al. LANCET NEUROLOGY
- Orexin receptor antagonists as therapeutic agents for insomnia
- (2013) Ana C. Equihua et al. Frontiers in Pharmacology
- Orexin receptor antagonism for treatment of insomnia: A randomized clinical trial of suvorexant
- (2012) W. J. Herring et al. NEUROLOGY
- Efficacy of Eight Months of Nightly Zolpidem: A Prospective Placebo-Controlled Study
- (2012) Surilla Randall et al. SLEEP
- Effects of eszopiclone on safety, subjective measures of efficacy, and quality of life in elderly and nonelderly Japanese patients with chronic insomnia, both with and without comorbid psychiatric disorders: a 24-week, randomized, double-blind study
- (2012) Naohisa Uchimura et al. Annals of General Psychiatry
- STOP Questionnaire
- (2008) Frances Chung et al. ANESTHESIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started